Bank Of Hawaii Bristol Myers Squibb CO Transaction History

Bank Of Hawaii

$2.38 Billion
Q3 2024

A detailed history of Bank Of Hawaii transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bank Of Hawaii holds 16,815 shares of BMY stock, worth $988,385. This represents 0.04% of its overall portfolio holdings.

Number of Shares

16,815

Previous 17,666 4.82%

Holding current value

$988,385

Previous $733,000 18.69%

% of portfolio

0.04%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$39.66 - $51.75 $33,750 - $44,039	-851 Reduced 4.82%	16,815 $870,000
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $9,780 - $12,876	-243 Reduced 1.36%	17,666 $733,000
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $17,128 - $19,420	357 Added 2.03%	17,909 $971,000
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $24,676 - $29,445	-509 Reduced 2.82%	17,552 $900,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $71,146 - $79,553	-1,229 Reduced 6.37%	18,061 $1.05 Million
Q2 2023 Aug 09, 2023	SELL	$63.71 - $70.74 $64,856 - $72,013	-1,018 Reduced 5.01%	19,290 $1.23 Million
Q1 2023 May 10, 2023	SELL	$65.71 - $74.53 $111,904 - $126,924	-1,703 Reduced 7.74%	20,308 $1.41 Million
Q4 2022 Jan 30, 2023	SELL	$68.48 - $81.09 $26,090 - $30,895	-381 Reduced 1.7%	22,011 $1.58 Million
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $172 - $102,120	-1,329 Reduced 5.6%	22,392 $1.59 Million
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $35,801 - $39,430	-493 Reduced 2.04%	23,721 $1.83 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $22,440 - $26,907	-365 Reduced 1.49%	24,214 $1.77 Million
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $38,667 - $45,076	-721 Reduced 2.85%	24,579 $1.53 Million
Q3 2021 Nov 08, 2021	SELL	$59.17 - $69.31 $27,514 - $32,229	-465 Reduced 1.8%	25,300 $1.5 Million
Q2 2021 Jul 22, 2021	SELL	$61.91 - $67.42 $312,397 - $340,201	-5,046 Reduced 16.38%	25,765 $1.72 Million
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $69,309 - $77,952	-1,168 Reduced 3.65%	30,811 $1.95 Million
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $199,203 - $225,733	3,450 Added 12.09%	31,979 $1.98 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $317,587 - $351,929	-5,530 Reduced 16.24%	28,529 $1.72 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $132,390 - $154,777	2,415 Added 7.63%	34,059 $2 Million
Q1 2020 May 13, 2020	BUY	$46.4 - $67.43 $15,126 - $21,982	326 Added 1.04%	31,644 $1.76 Million
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $249,051 - $324,865	5,061 Added 19.27%	31,318 $2.01 Million
Q3 2019 Nov 15, 2019	BUY	$42.77 - $50.71 $131,688 - $156,136	3,079 Added 13.28%	26,257 $1.33 Million
Q2 2019 Aug 15, 2019	SELL	$44.62 - $49.34 $355,621 - $393,239	-7,970 Reduced 25.59%	23,178 $1.05 Million
Q1 2019 May 10, 2019	SELL	$45.12 - $53.8 $117,447 - $140,041	-2,603 Reduced 7.71%	31,148 $1.49 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $10,580 - $13,720	-217 Reduced 0.64%	33,751 $1.75 Million
Q3 2018 Nov 09, 2018	BUY	$55.19 - $62.25 $238,862 - $269,418	4,328 Added 14.6%	33,968 $2.11 Million
Q2 2018 Aug 06, 2018	SELL	$50.53 - $62.98 $51,944 - $64,743	-1,028 Reduced 3.35%	29,640 $1.64 Million
Q1 2018 May 04, 2018	SELL	$59.92 - $68.98 $9,287 - $10,691	-155 Reduced 0.5%	30,668 $1.94 Million
Q4 2017 Feb 12, 2018	SELL	$59.94 - $65.35 $31,768 - $34,635	-530 Reduced 1.69%	30,823 $1.89 Million
Q3 2017 Nov 03, 2017	BUY	$55.23 - $63.74 $31,812 - $36,714	576 Added 1.87%	31,353 $2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	30,777	30,777 $1.72 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Hawaii, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Hawaii with notifications on news.

Account